Cover - USD ($) |
12 Months Ended | ||
|---|---|---|---|
Jun. 30, 2026 |
Aug. 18, 2026 |
Dec. 31, 2025 |
|
| Cover [Abstract] | |||
| Document Type | 10-K/A | ||
| Amendment Flag | true | ||
| Amendment Description | Intelligent Bio Solutions Inc. (the “Company,” “we,” “us” or “our”) is filing this Amendment No. 1 on Form 10-K/A (this “Amendment No. 1”) to amend its Annual Report on Form 10-K for the fiscal year ended June 30, 2026 (the “Original 10-K”), originally filed with the U.S. Securities and Exchange Commission (the “SEC”) on August 19, 2026, solely for the purpose of amending and restating in their entirety Item 11, Item 13, and Item 15 of the Original 10-K, as described below. Specifically, this Amendment No. 1 is being filed to (i) revise Item 11 to remove duplicate disclosure regarding Outstanding Equity Awards at Fiscal Year End that appeared immediately following the footnotes to the Summary Compensation Table; (ii) revise Item 13 to add disclosure regarding capital raising transactions in which a beneficial owner of more than 5% of our outstanding common stock participated, clarify the process used to approve related party transactions, and to make related and other clarifying revisions; (iii) revise the Exhibit Index in Item 15 to delete a duplicate entry for a Certificate of Amendment to the Company’s Certificate of Incorporation listed as Exhibit 3.1 and to replace that entry with the Company’s Amended and Restated Certificate of Incorporation; and (iv) revise the Exhibit Index in Item 15 to remove two duplicate entries previously listed as Exhibits 10.39 and 10.40 and to make conforming updates to the exhibit numbering and references. Pursuant to Rule 12b-15 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), this Amendment No. 1 also contains new certifications by the principal executive officer and the principal financial officer as required by Section 302 of the Sarbanes-Oxley Act of 2002. Accordingly, Item 15 of Part IV is also amended to include the currently dated certifications of our principal executive officer and principal financial officer as exhibits. Because no financial statements have been included in this Amendment No. 1 and this Amendment No. 1 does not contain or amend any disclosure with respect to Items 307 and 308 of Regulation S-K, paragraphs 3, 4 and 5 of the certifications have been omitted. In addition, because no financial statements are included in this Amendment No. 1, new certifications of our principal executive officer and principal financial officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 are not required to be included with this Amendment No. 1. Except as described above, no other changes have been made to the Original 10-K. The Original 10-K continues to speak as of the date of the Original 10-K, and we have not updated the disclosures contained therein to reflect any events that have occurred as of a date subsequent to the date of the Original 10-K. Accordingly, this Amendment No. 1 should be read in conjunction with the Original 10-K. Defined terms used, but not defined, herein have the meanings ascribed to them in the Original 10-K. | ||
| Document Annual Report | true | ||
| Document Transition Report | false | ||
| Document Period End Date | Jun. 30, 2026 | ||
| Document Fiscal Period Focus | FY | ||
| Document Fiscal Year Focus | 2026 | ||
| Current Fiscal Year End Date | --06-30 | ||
| Entity File Number | 001-39825 | ||
| Entity Registrant Name | Intelligent Bio Solutions Inc. | ||
| Entity Central Index Key | 0001725430 | ||
| Entity Tax Identification Number | 82-1512711 | ||
| Entity Incorporation, State or Country Code | DE | ||
| Entity Address, Address Line One | 135 West | ||
| Entity Address, Address Line Two | 41st Street | ||
| Entity Address, Address Line Three | 5th Floor | ||
| Entity Address, City or Town | New York | ||
| Entity Address, State or Province | NY | ||
| Entity Address, Postal Zip Code | 10036 | ||
| City Area Code | (646) | ||
| Local Phone Number | 790-5756 | ||
| Title of 12(b) Security | Common Stock, par value $0.01 per share | ||
| Trading Symbol | INBS | ||
| Security Exchange Name | NASDAQ | ||
| Entity Well-known Seasoned Issuer | No | ||
| Entity Voluntary Filers | No | ||
| Entity Current Reporting Status | Yes | ||
| Entity Interactive Data Current | Yes | ||
| Entity Filer Category | Non-accelerated Filer | ||
| Entity Small Business | true | ||
| Entity Emerging Growth Company | false | ||
| Entity Shell Company | false | ||
| Entity Public Float | $ 11,712,017 | ||
| Entity Common Stock, Shares Outstanding | 3,027,470 | ||
| Documents Incorporated by Reference | None | ||
| ICFR Auditor Attestation Flag | false | ||
| Document Financial Statement Error Correction [Flag] | false | ||
| Auditor Firm ID | 1195 | ||
| Auditor Name | UHY LLP | ||
| Auditor Location | Melville, NY |